Indicia Biotechnology, Platine Pharma Services S.A.S., Transgene deal

Platine will acquire Indicia's immune-monitoring activities, which includes the development of immunoassays as well as the Immunoline platform to assess the immunogenicity risk of biologics, in a stock deal. The deal will be submitted to Indicia and Platine shareholders on July 31 for approval. ...